These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 22030709)
1. Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial. Hoexter MQ; de Souza Duran FL; D'Alcante CC; Dougherty DD; Shavitt RG; Lopes AC; Diniz JB; Deckersbach T; Batistuzzo MC; Bressan RA; Miguel EC; Busatto GF Neuropsychopharmacology; 2012 Feb; 37(3):734-45. PubMed ID: 22030709 [TBL] [Abstract][Full Text] [Related]
2. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder. Hoexter MQ; Dougherty DD; Shavitt RG; D'Alcante CC; Duran FL; Lopes AC; Diniz JB; Batistuzzo MC; Evans KC; Bressan RA; Busatto GF; Miguel EC Eur Neuropsychopharmacol; 2013 Jul; 23(7):569-80. PubMed ID: 22841131 [TBL] [Abstract][Full Text] [Related]
3. Cortico-striato-thalamo-cortical circuit abnormalities in obsessive-compulsive disorder: A voxel-based morphometric and fMRI study of the whole brain. Tang W; Zhu Q; Gong X; Zhu C; Wang Y; Chen S Behav Brain Res; 2016 Oct; 313():17-22. PubMed ID: 27388149 [TBL] [Abstract][Full Text] [Related]
13. Structural brain abnormalities correlate with clinical features in patients with drug-naïve OCD: A DARTEL-enhanced voxel-based morphometry study. Tang W; Huang X; Li B; Jiang X; Li F; Xu J; Yang Y; Gong Q Behav Brain Res; 2015 Nov; 294():72-80. PubMed ID: 26241173 [TBL] [Abstract][Full Text] [Related]
14. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. Simpson HB; Gorfinkle KS; Liebowitz MR J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of combination of fluoxetine and cognitive behavioral therapy and fluoxetine alone for the treatment of obsessive compulsive disorder. Giasuddin NA; Nahar JS; Morshed NM; Balhara YP; Sobhan MA Pak J Pharm Sci; 2013 Jan; 26(1):95-8. PubMed ID: 23261733 [TBL] [Abstract][Full Text] [Related]
16. The effects of cognitive behavioral therapy on resting-state functional brain network in drug-naive patients with obsessive-compulsive disorder. Li P; Yang X; Greenshaw AJ; Li S; Luo J; Han H; Liu J; Zhong Z; Guo Z; Xiong H; Yao S; Chen Y; Sun J; Li Z Brain Behav; 2018 May; 8(5):e00963. PubMed ID: 29761016 [TBL] [Abstract][Full Text] [Related]
17. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study. Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971 [TBL] [Abstract][Full Text] [Related]
18. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. Szeszko PR; Christian C; Macmaster F; Lencz T; Mirza Y; Taormina SP; Easter P; Rose M; Michalopoulou GA; Rosenberg DR Am J Psychiatry; 2008 Oct; 165(10):1299-307. PubMed ID: 18413702 [TBL] [Abstract][Full Text] [Related]
19. Widespread structural brain changes in OCD: a systematic review of voxel-based morphometry studies. Piras F; Piras F; Chiapponi C; Girardi P; Caltagirone C; Spalletta G Cortex; 2015 Jan; 62():89-108. PubMed ID: 23582297 [TBL] [Abstract][Full Text] [Related]
20. Biological heterogeneity of obsessive-compulsive disorder: A voxel-based morphometric study based on dimensional assessment. Okada K; Nakao T; Sanematsu H; Murayama K; Honda S; Tomita M; Togao O; Yoshiura T; Kanba S Psychiatry Clin Neurosci; 2015 Jul; 69(7):411-21. PubMed ID: 25556718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]